NovoCure (NVCR) EBT Margin Growth (3y) (2017 - 2026)
NovoCure (NVCR) EBT Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,391.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,114.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -176.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | 3,598.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3,598.00 |
| Mar 31, 2026 | 202.00 |
| Dec 31, 2025 | 186.00 |
| Sep 30, 2025 | -8.00 |
| Jun 30, 2025 | -545.00 |
| Mar 31, 2025 | -1,772.00 |
| Dec 31, 2024 | -1,504.00 |
| Sep 30, 2024 | -603.00 |
| Jun 30, 2024 | -520.00 |
| Mar 31, 2024 | -2,082.00 |
| Dec 31, 2023 | -3,493.00 |
| Sep 30, 2023 | -4,620.00 |
| Jun 30, 2023 | -4,626.00 |
| Mar 31, 2023 | -3,610.00 |
| Dec 31, 2022 | -2,375.00 |
| Sep 30, 2022 | -1,929.00 |
| Jun 30, 2022 | -1,653.00 |
| Mar 31, 2022 | 975.00 |
| Dec 31, 2021 | -366.00 |
| Sep 30, 2021 | 392.00 |